- Q1 2024 Theratechnologies Inc Earnings Call TranscriptApr 10, 2024$1.48 (-3.90%)Earnings
- Q4 2023 Theratechnologies Inc Earnings Call TranscriptFeb 21, 2024$1.7 (+1.19%)Earnings
- Q3 2023 Theratechnologies Inc Earnings Call TranscriptSep 26, 2023$1.75 (-16.19%)Earnings
- Q2 2023 Theratechnologies Inc Earnings Call TranscriptJul 12, 2023$3.6 (-7.37%)Earnings
- Theratechnologies Inc Investors & Analysts: Phase 1 Trial Update TranscriptJun 13, 2023
- Theratechnologies Inc Annual Shareholders Meeting TranscriptMay 09, 2023
- Q1 2023 Theratechnologies Inc Earnings Call TranscriptApr 12, 2023$3.12 (-3.40%)Earnings
- Q4 2022 Theratechnologies Inc Earnings Call TranscriptFeb 28, 2023$3.8 (-0.71%)Earnings
- Q3 2022 Theratechnologies Inc Earnings Call TranscriptOct 13, 2022$8.16 (-1.92%)Earnings
- Q2 2022 Theratechnologies Inc Earnings Call TranscriptJul 14, 2022$8.68 (+5.85%)Earnings
- Q1 2022 Theratechnologies Inc Earnings Call TranscriptApr 13, 2022$10.36 (+3.19%)Earnings
- Q4 2021 Theratechnologies Inc Earnings Call TranscriptFeb 24, 2022$11.04 (-7.69%)Earnings
- Theratechnologies Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- Q3 2021 Theratechnologies Inc Earnings Call TranscriptOct 13, 2021$14.28 (+2.00%)Earnings
- Theratechnologies Inc at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 12, 2021
- Theratechnologies Inc Discuss on Treatment of NASH Key Opinion Leader Webinar TranscriptSep 13, 2021
- Q2 2021 Theratechnologies Inc Earnings Call TranscriptJul 15, 2021$14 (-4.89%)Earnings
- Theratechnologies Inc Key Opinion Leader Webinar TranscriptJun 21, 2021
- Theratechnologies Inc Annual Shareholders Meeting TranscriptMay 13, 2021
- Theratechnologies Inc at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 21, 2021
- Q1 2021 Theratechnologies Inc Earnings Call TranscriptApr 14, 2021$14.6 (-4.58%)Earnings
- Q4 2020 Theratechnologies Inc Earnings Call TranscriptFeb 25, 2021$12.4 (-1.59%)Earnings
- Q3 2020 Theratechnologies Inc Earnings Call TranscriptOct 15, 2020$8.88 (+5.71%)Earnings
- Theratechnologies Inc. - Special Call TranscriptSep 10, 2020
- Theratechnologies Inc Annual Shareholders Meeting TranscriptJul 16, 2020
- Q2 2020 Theratechnologies Inc Earnings Call TranscriptJul 15, 2020$8.64 (-1.82%)Earnings
- Q1 2020 Theratechnologies Inc Earnings Call TranscriptApr 14, 2020$8.12 (+11.85%)Earnings
- Q4 2019 Theratechnologies Inc Earnings Call TranscriptFeb 25, 2020$9.66 (-1.43%)Earnings
- Theratechnologies Inc Corporate Analyst Meeting TranscriptOct 23, 2019
- Q3 2019 Theratechnologies Inc Earnings Call TranscriptOct 08, 2019$14.52 (-12.74%)Earnings
- Q2 2019 Theratechnologies Inc Earnings Call TranscriptJul 11, 2019$18.79 (-2.73%)Earnings
- Theratechnologies Inc to Present New Development Strategy for Tesamorelin Conference Call TranscriptJun 17, 2019
- Q1 2019 Theratechnologies Inc Earnings Call TranscriptApr 04, 2019$24.72 (-5.79%)Earnings
- Katana Biopharma Inc., Theratechnologies Inc. - M&A Call TranscriptFeb 25, 2019
- Q4 2018 Theratechnologies Inc Earnings Call TranscriptFeb 21, 2019$25.06 (+9.34%)Earnings
Q4 2022 Theratechnologies Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Theratechnologies Fourth Quarter Fiscal Year 2022 Earnings Call. We would like to remind everyone that all figures on this call are quoted in U.S. dollars. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session with analysts.
(Operator Instructions) I would like to remind everyone that this conference call is being recorded today, February 28, 2023, at 8:30 a.m. Eastern Time.
I will now turn the call over to Ms. Elif McDonald, Head of Investor Relations. Ms. McDonald. Please go ahead.
Thank you, MJ, and good morning, everyone. On the call today will be our President and Chief Executive Officer, Mr. Paul Lévesque; and Chief Financial Officer, Mr. Philippe Dubuc. During our Q&A session, we will be joined by Dr. Christian Marsolais, Chief Medical Officer; and Mr. John Leasure, our Global Commercial Officer.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)